Both in Pharmaceuticals
Nkarta vs Journey Medical
Over the past year NKTX returned −27.5% and DERM returned −32.0%; their daily moves had a correlation of 0.18.
NKTX −27.5% DERM −32.0%Growth of $1, one year, split-adjusted
| Metric | NKTX | DERM |
|---|---|---|
| Price | $1.77 | $4.92 |
| Market cap | $126.8M | $138.7M |
| Today | +1.72% | −5.84% |
| 1 month | −40.0% | −32.2% |
| 6 months | −42.7% | −2.5% |
| Year to date | −4.3% | −36.3% |
| 1 year | −27.5% | −32.0% |
| Revenue growth (YoY) | — | +18.9% |
| Gross margin | — | 65.6% |
| Net margin | — | −1.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.1× |
| Net cash | $182.8M | -$245.0K |
| Dividend yield | — | — |
| Volatility (60d) | 61.7% | 59.2% |
| Short % of float | 8.7% | 25.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).